Invesco Pharmaceuticals ETF
PJP
90 hedge funds and large institutions have $293M invested in Invesco Pharmaceuticals ETF in 2014 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 30 increasing their positions, 34 reducing their positions, and 6 closing their positions.
67% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 6
6% more capital invested
Capital invested by funds: $276M → $293M (+$17.4M)
5% more funds holding
Funds holding: 86 → 90 (+4)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
0.16% less ownership
Funds ownership: 23.68% → 23.51% (-0.16%)
12% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 34
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UCFA
United Capital Financial Advisors
Irving,
Texas
|
+$4.15M |
| 2 |
Envestnet Asset Management
Chicago,
Illinois
|
+$3.67M |
| 3 |
U
UBS
Zurich,
Switzerland
|
+$3.43M |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$2.96M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.66M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FMP
Financial Management Professionals
Austin,
Texas
|
-$3.41M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$2.7M |
| 3 |
AP
Advisors Preferred
Rockville,
Maryland
|
-$1.93M |
| 4 |
Morgan Stanley
New York
|
-$1.7M |
| 5 |
CWM
Concert Wealth Management
San Jose,
California
|
-$1.44M |
PJP Hedge Fund Activity: Q3 2014 in Review
90 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in Invesco Pharmaceuticals ETF (PJP) for Q3 2014, worth a combined $293M — up 6.3% from $276M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new PJP positions and 6 closed out — a net gain of 4 holders — while 30 added to existing stakes and 34 trimmed.
The largest buyer was United Capital Financial Advisors, adding an estimated $4.15M. The largest seller was Financial Management Professionals, exiting entirely with an estimated $3.41M sold.
- 90 institutional investors held Invesco Pharmaceuticals ETF (PJP) as of Q3 2014, up from 86 in Q2 2014.
- Funds reported $293M of Invesco Pharmaceuticals ETF stock for Q3 2014, up 6.3% quarter-over-quarter.
- 10 funds opened new Invesco Pharmaceuticals ETF positions in Q3 2014 and 6 closed out, a net change of +4 holders.
- The largest Invesco Pharmaceuticals ETF buyer in Q3 2014 was United Capital Financial Advisors, an estimated $4.15M added.
- The largest Invesco Pharmaceuticals ETF seller in Q3 2014 was Financial Management Professionals, an estimated $3.41M sold.
Based on aggregated 13F filings for Q3 2014.